Erdolyt 300 mg is a mucolytic drug used in the treatment of acute and chronic respiratory diseases. It also improves the symptoms associated with short episodes of chronic bronchitis.
Theropeutic Class
Cough expectorants & mucolytics
Pharmacology
Erdolyt 300 mg is a prodrug that is metabolised into N-thiodiglycolyl-homocysteine whereby free thiol groups are formed leading to the opening of the disulphide bonds of the bronchial mucoproteins, thus reducing the viscosity of mucus and purulent sputum. It also antagonises the local formation of free radicals and inhibits elastase enzyme activity and bacterial adhesion to epithelial cells.
Dosage & Administration of Erdolyt 300 mg
The usual dose of elderly patients and adults above 18 years is 1 capsule twice daily for 10 days. But study shows that in chronic cases Erdolyt 300 mg can be given up to 12 months or as directed by the physician. Erdolyt 300 mg capsule may be taken with or without food.
Dosage of Erdolyt 300 mg
The usual dose of elderly patients and adults above 18 years is 1 capsule twice daily for 10 days. But study shows that in chronic cases Erdolyt 300 mg can be given up to 12 months or as directed by the physician. Erdolyt 300 mg capsule may be taken with or without food.
Contraindications
It is contraindicated to patients who have hypersensitivity to Erdolyt 300 mg. It should not be used in patients with creatinine clearance <25 ml/min, or with severe liver failure.
Side Effects of Erdolyt 300 mg
Common side effect is epigastric pain. Other side effects include headache, cold, taste alterations, nausea, vomiting, diarrhea, angioedema and other skin allergic reactions.
Pregnancy & Lactation
The use of Erdolyt 300 mg in pregnant or breast-feeding women is not recommended.
Precautions & Warnings
It should be used with caution in mild liver failure. In that case, should not exceed a dose of 300 mg per day.
Storage Conditions
Keep in a dry place away from light and heat. Keep out of reach of children
Erdolyt 300 mg is a prodrug that is metabolised into N-thiodiglycolyl-homocysteine whereby free thiol groups are formed leading to the opening of the disulphide bonds of the bronchial mucoproteins, thus reducing the viscosity of mucus and purulent sputum. It also antagonises the local formation of free radicals and inhibits elastase enzyme activity and bacterial adhesion to epithelial cells.
Pregnancy
The use of Erdolyt 300 mg in pregnant or breast-feeding women is not recommended.
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.